Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 6Colonic Neoplasms 2Uveal Melanoma 1Uterine Cervical Neoplasms 1Rectal Neoplasms 1Peritoneal Neoplasms 1Pancreatitis, Acute Necrotizing 1Pancreatic Fistula 1Pancreatic Cyst 1Neoplasm Metastasis 1Melanoma 1Malignant Female Reproductive System Neoplasm 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Krukenberg Tumor 1Hyperthermia 1Fallopian Tube Neoplasms 1Eye Neoplasms 1Endometrial Neoplasms 1Complex Ovarian Cyst 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Burkitt Lymphoma 1Anastomotic Leak 1Abdominal Injuries 1Abdominal Abscess 1

Interventions

Therapeutics 1Mental Status and Dementia Tests 1Laparotomy 1Hydromorphone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Malignant Female Reproductive System Neoplasm × Laparotomy × Clear all
NCT04258631 2024-10-16

Liposomal Bupivacaine With or Without Hydromorphone for the Improvement of Pain Control After Laparotomy in Patients With Gynecological Malignancies

Mayo Clinic

Phase 4 Completed
105 enrolled 22 charts

Malignant Female Reproductive System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡